Sign Up to like & get
recommendations!
0
Published in 2018 at "Cancer"
DOI: 10.1002/cncr.31550
Abstract: Myelodysplastic syndromes (MDS) encompass a heterogeneous group of clonal hematopoietic stem cell disorders characterized by a broad clinical spectrum related to ineffective hematopoiesis leading to unilineage or multilineage cytopenias, with a high propensity for transformation…
read more here.
Keywords:
overload patients;
myelodysplastic syndromes;
patients mds;
iron overload ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2022 at "Therapeutic Advances in Hematology"
DOI: 10.1177/20406207221125990
Abstract: Background: Myelodysplastic syndrome (MDS) is associated with persistent immune activation. High mobility group box-1 (HMGB1) is a ubiquitous, functionally diverse, non-histone intranuclear protein. During acute and chronic inflammatory states, HMGB1 is actively released by inflammatory…
read more here.
Keywords:
myelodysplastic syndrome;
circulating hmgb1;
iqr;
hmgb1 ... See more keywords
Sign Up to like & get
recommendations!
1
Published in 2018 at "Blood"
DOI: 10.1182/blood-2018-99-113524
Abstract: Introduction: The revised version of the International Prognostic Scoring System, (IPSS-R), is an accepted standard for assessing the prognosis of patients with MDS. Its usefulness may be further improved by integrating molecular findings. However, such…
read more here.
Keywords:
risk;
patients mds;
ipss;
expression ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2019 at "Blood"
DOI: 10.1182/blood-2019-123676
Abstract: Background: Next-generation sequencing (NGS) technologies have led to the discovery of recurrently-mutated genes in acute myeloid leukemia (AML) and myelodysplastic syndromes (MDS). These mutations have proven useful in diagnosis, prognostication, and prediction of treatment response…
read more here.
Keywords:
risk;
aml patients;
molecular data;
patients mds ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2019 at "Blood"
DOI: 10.1182/blood-2019-125147
Abstract: BACKGROUND: Most patients with myelodysplastic syndromes (MDS) describe difficulty sleeping (Luskin et al Br J Haem 2017) and sleep disturbance is a likely contributor to the fatigue experienced by patients with MDS and acute leukemia.…
read more here.
Keywords:
acute leukemia;
patients mds;
consultancy;
research funding ... See more keywords
Sign Up to like & get
recommendations!
1
Published in 2017 at "Sultan Qaboos University medical journal"
DOI: 10.18295/squmj.2017.17.03.005
Abstract: Clonal cytogenetic abnormalities have been reported among 30-80% of patients with myelodysplastic syndromes (MDS); however, 20-70% of patients with MDS show a normal karyotype that may nevertheless harbour a cryptic genetic alteration. Earlier reports have…
read more here.
Keywords:
profile omani;
myelodysplastic syndromes;
patients mds;
omani patients ... See more keywords
Sign Up to like & get
recommendations!
1
Published in 2022 at "Annals of Laboratory Medicine"
DOI: 10.3343/alm.2022.42.3.299
Abstract: Myelodysplastic syndrome (MDS) is a diverse hematological malignancy with a wide spectrum of presentations and implications. Treatment strategies for patients with MDS heavily rely on prognostic scoring systems, such as the revised international prognostic scoring…
read more here.
Keywords:
syndromes bone;
bone marrow;
myelodysplastic syndromes;
patients mds ... See more keywords